Warfarin is often used for the prevention of deep vein thrombosis ... This leads to a dose-response relationship which makes toxicity as well as ineffective treatment a frequent possibility.

Latest prescription information about Warfarin. Learn how to pronounce the drug's name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its ...

A host of potential new oral anticoagulant agents, which could become much-needed replacements for warfarin, are making good progress in development, with at least two agents now in phase 3 trials.

When participants undergoing elective knee or hip replacement surgery (n=1650) were randomized to pharmacogenetic dosing or a clinical algorithm for dosing of prophylactic warfarin, combined ...

We often start patients on 5 mg daily and don't find out who is very sensitive to warfarin until their INR is four or more, indicating an overdose," said Brian F. Gage, MD, MSc, professor of ...

We often start patients on 5 mg daily and don't find out who is very sensitive to warfarin until their INR is four or more, indicating an overdose," said Brian F. Gage, MD, MSc, professor of ...

Problems with warfarin are the most common reason for emergency-room visits by older adults, according to the Centers for Disease Control and Prevention. Atrial-fibrillation patients, in contrast ...

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- In a new study, researchers at Hospital for Special Surgery (HSS), Washington University School of Medicin ...

Find patient medical information for Warfarin on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

Warfarin, which is probably best known as Coumadin, blocks the synthesis of factors that are necessary for the blood to clot, but blood levels must be carefully regulated to prevent overdose and ...

A host of potential new oral anticoagulant agents, which could become much-needed replacements for warfarin, are making good progress in development, with at least two agents now in phase 3 trials.

Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with ...